Skip to main content
Watch Insiders
ATHESector not reported

Alterity Therapeutics Ltd - ADR (ATHE) Insider Trading

In the last 90 days, 1 Alterity Therapeutics Ltd - ADR (ATHE) insider reported 1 open-market purchase totaling $23,810 and no sales. The most recent open-market purchase was reported on Aug 31, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$23,810
Corporate buyers
1
Latest transaction
Aug 31, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 31, 2026Peter Ashley MarksCorporate insiderOpen Market Purchase47,620$0.50$23,810

Common questions

ATHE insider trading FAQ

Are ATHE insiders buying or selling?
Over the last 90 days, ATHE insiders were net buyers, reporting $23,810 of open-market purchases and $0.00 of sales.
When was the last ATHE insider purchase?
The most recent open-market purchase of Alterity Therapeutics Ltd - ADR stock by an insider was reported on Aug 31, 2026, one of 1 purchase in the last 90 days.
Where does ATHE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Alterity Therapeutics Ltd - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.